Patent Assignment
Reel/Frame 051424/0568
Corrective Assignment to Correct the 2ND Inventor's Name Previously Recorded at Reel: 51327 Frame: 101. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2019-12-26
Pages: 10
Assignee
IMMUNOCORE LIMITED
101 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, ENGLAND, OX14 4RY, UNITED KINGDOM
Covered Property
(1)
Peptides
Application:
15/778,204 →
Publication:
US 2018/0340018
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 18, 2019
From: POWLESLAND, ALEX; KLEIJNE, MAURITS
To: IMMUNOCORE LIMITED
Reel/Frame 051327/0101 →
Security Interest
Nov 6, 2020
From: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
To: OXFORD FINANCE LUXEMBOURG S.À R.L., REGISTERED WITH THE LUXEMBOURG COMMERCIAL REGISTER UNDER NUMBER B243395, ACTING IN RESPECT OF ITS COMPARTMENT 1
Reel/Frame 054344/0218 →
Assignment of Assignor's Interest
Nov 30, 2020
From: IMMUNOCORE LTD.
To: IMMUNOCORE LTD.; ADAPTIMMUNE THERAPEUTICS PLC
Reel/Frame 054496/0211 →
Assignment of Assignor's Interest
Jan 7, 2021
From: SUN, MEIDAI
To: IMMUNOCORE LIMITED
Reel/Frame 054847/0009 →
Assignment of Assignor's Interest
Feb 4, 2021
From: ADAPTIMMUNE THERAPEUTICS PLC
To: ADAPTIMMUNE LIMITED
Reel/Frame 055153/0407 →
Release of Security Interest
Nov 10, 2022
From: OXFORD FINANCE LUXEMBOURG S.À R.L
To: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
Reel/Frame 061916/0493 →